Open Philanthropy recommended a grant of $2,500,000 over three years to Harvard University to support research led by Dr. Donald Ingber on a novel class of antiviral drugs with special emphasis on viruses with pandemic potential.
This falls within Open Philanthropy’s focus area of scientific research, specifically within its interest in science supporting biosecurity and pandemic preparedness.